- Home
- AUPH vs COMM Comparison
AUPH vs COMM Comparison
Compare AUPH & COMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- COMM
- Stock Information
- Founded
- AUPH 1993
- COMM 1976
- Country
- AUPH Canada
- COMM United States
- Employees
- AUPH N/A
- COMM N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- COMM Radio And Television Broadcasting And Communications Equipment
- Sector
- AUPH Health Care
- COMM Technology
- Exchange
- AUPH Nasdaq
- COMM Nasdaq
- Market Cap
- AUPH 1.1B
- COMM 1.3B
- IPO Year
- AUPH 1999
- COMM 2013
- Fundamental
- Price
- AUPH $8.86
- COMM $7.53
- Analyst Decision
- AUPH Strong Buy
- COMM Hold
- Analyst Count
- AUPH 2
- COMM 5
- Target Price
- AUPH $11.50
- COMM $4.88
- AVG Volume (30 Days)
- AUPH 1.9M
- COMM 5.8M
- Earning Date
- AUPH 07-31-2025
- COMM 08-07-2025
- Dividend Yield
- AUPH N/A
- COMM N/A
- EPS Growth
- AUPH N/A
- COMM N/A
- EPS
- AUPH 0.27
- COMM 3.42
- Revenue
- AUPH $247,295,000.00
- COMM $4,417,100,000.00
- Revenue This Year
- AUPH $12.15
- COMM $21.50
- Revenue Next Year
- AUPH $18.31
- COMM $8.30
- P/E Ratio
- AUPH $33.04
- COMM $2.21
- Revenue Growth
- AUPH 29.20
- COMM 16.19
- 52 Week Low
- AUPH $5.20
- COMM $1.32
- 52 Week High
- AUPH $10.67
- COMM $8.67
- Technical
- Relative Strength Index (RSI)
- AUPH 64.10
- COMM 55.72
- Support Level
- AUPH $7.36
- COMM $7.67
- Resistance Level
- AUPH $9.10
- COMM $8.67
- Average True Range (ATR)
- AUPH 0.44
- COMM 0.41
- MACD
- AUPH 0.10
- COMM -0.07
- Stochastic Oscillator
- AUPH 89.53
- COMM 55.29
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).